JCRB1603 hTf18-10C
Cell information
Cell type：general cells (View Pricing Information)
| JCRB No. | JCRB1603 | Cell Name | hTf18-10C |
|---|---|---|---|
| Profile | This cell line produce monoclonal antibody against human transferrin. | Other Name | |
| Animal | mouse x mouse | Strain | BALB/c |
| Genus | hybridoma | Species | |
| Sex | Age | ||
| Identity | not done | Tissue for Primary Cancer | |
| Case history | Metastasis | ||
| Tissue Metastasized | Genetics | ||
| Life Span | infinite | Crisis PDL | |
| Morphology | lymphocyte-like | Character | This cell line produce monoclonal antibody against human transferrin. Antibody's subclass; IgG1, kappa. BALB/c mouse spleen x P3U1 myeloma (BALB/c) |
| Classify | hybridoma | Established by | Mebiopharm Co.,Ltd |
| Registered by | Mebiopharm Co.,Ltd | Regulation for Distribution | |
| Comment | Year | 2011 | |
| Medium | RPMI1640 medium with 10% FBS. | Methods for Passages | dilution |
| Cell Number on Passage | Race | ||
| CO2 Conc. | 5% | Tissue Sampling | |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | not tested | Detected RNA Virus | not tested | ||||||
| Images |
|---|
        |
LOT Information
| Cell No. | JCRB1603 | Cell Name | hTf18-10C |
|---|---|---|---|
| LOT No. | 08082014 | Lot Specification | distribution |
| Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA027K03911) | Temperature | 37 C |
| Cell Density at Seeding | 0.57-6.7x10^5 cells/ml | Methods for Passages | Dilution |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.29x10^6 |
| Viability at cell freezing (%) | 85.1 | Antibiotics Used | free |
| Passage Number | p4* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | |
| Adhesion | No | Exoteric Gene | NT |
| Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5 % |
| Viability immediately after thawing (%) | Additional information |
| Images |
|---|
|
|